Reported Case of Asymptomatic SARS-CoV-2-carriage in the Child with Severe Chronic Disease

QR Code

Reported Case of Asymptomatic SARS-CoV-2-carriage in the Child with Severe Chronic Disease

.

Saved in:

Bibliographic Details
Main Authors:	Irina I. Spichak, Larisa V. Moiseeva, Irina P. Karimova, Rafiia K. Babik, Galina N. Kireeva
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2020-08-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/1863
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular genetic analysis SARS-CoV-2 of asymptomatic patients in Rostov region
by: O. A. Perevesentsev, et al.
Published: (2020-09-01)

Presence of neutralizing SARS‐CoV‐2 antibodies in asymptomatic population of N'Djamena, Chad
by: Andrillene Laure Deutou Wondeu, et al.
Published: (2024-01-01)

Pneumothorax and Pneumomediastinum in SARS-CoV-2 Infection
by: Cătălina Aldea, et al.
Published: (2025-06-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Silent hypoxemia in a patient with severe SARS-CoV-2 pneumonia
by: A. D. Palman, et al.
Published: (2020-12-01)

Practical Challenges in the Diagnosis of SARS-CoV-2 Infection in Children
by: Alina Petronela Bouari-Coblișan, et al.
Published: (2025-05-01)

Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein
by: Alexandra Rak, et al.
Published: (2025-05-01)

Structural proteins of SARS-CoV-2
by: O. V. Duvanova, et al.
Published: (2023-01-01)

The Intersection of SARS-CoV-2 and Diabetes
by: Jacob H. Nichols, et al.
Published: (2025-06-01)

SARS-CoV-2 severity prediction in young adults using artificial intelligence
by: K. V. Kas’janenko, et al.
Published: (2023-01-01)

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
by: Felicitas Ruiz, et al.
Published: (2024-10-01)

SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.
by: Mansi Patel, et al.
Published: (2025-03-01)

Prevalence of SARS-CoV-2 infection and immunity in a New York county in 2022 reveals frequent asymptomatic or undiagnosed infections.
by: Casey L Cazer, et al.
Published: (2025-01-01)

Pituitary Apoplexy in a Child with Short Stature and Possible Recent SARS-CoV-2 Infection
by: Carmen Gabriela Barbu, et al.
Published: (2025-06-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

SARS-CoV-2 Detection From Voice
by: Gadi Pinkas, et al.
Published: (2020-01-01)

Myocardial Damage in SARS-CoV-2 Infection
by: Elizabeth Sellén Sanchén, et al.
Published: (2020-11-01)

Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection
by: Mariangela Scavone, et al.
Published: (2025-07-01)

3,3′-Diindolylmethane Improves the Viral Pneumonia Outcomes After Influenza and SARS-CoV-2 Infection in Animal Models
by: Vsevolod Kiselev, et al.
Published: (2025-07-01)

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of 1,000 patients
by: G. P. Arutyunov, et al.
Published: (2020-12-01)

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Pancreatic islets as a SARS-CoV-2 target
by: O. V. Vorobеva
Published: (2023-01-01)

Megakaryocyte phenotyping in response to SARS-CoV-2 variants
by: Marcin A Sowa, et al.
Published: (2025-12-01)

Severity and duration of immune response in people of different age categories after SARS-CoV-2 revaccination
by: O. M. Drapkina, et al.
Published: (2023-12-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

Formation of Herd Immunity to SARS-CoV-2 in the Population of Moscow
by: M A Godkov, et al.
Published: (2022-03-01)

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes
by: Adi Anis Heusler, et al.
Published: (2025-12-01)

Corticosteroids in the treatment of SARS-CoV-2 related lung disease
by: V. T. Ivaschkin, et al.
Published: (2020-12-01)

Autoantibodies and SARS-CoV-2 infection: A case report
by: T. I. Kalenchic, et al.
Published: (2022-07-01)

Role of IFNγ in pathogenesis of SARS-CoV-2 infection
by: A. A. Artamonov, et al.
Published: (2022-11-01)

Antibiotic-associated syndrome in SARS-CoV-2 coronavirus infection
by: L. B. Golden, et al.
Published: (2023-01-01)

SARS-CoV-2-INDUCED MICROSCOPIC POLYANGIITIS: CLINICAL PROBLEM
by: Olga O. Gutsalenko, et al.
Published: (2025-05-01)

Copper(II) Inhibition of the SARS‐CoV‐2 Main Protease
by: Roberto A. Garza‐López, et al.
Published: (2025-07-01)

SARS-CoV-2 transmission pathways within the indoor environment
by: Islam El Jaddaoui, et al.
Published: (2025-06-01)

Obliteration of oral and maxillofacial region by SARS-CoV-2 infection
by: Shunmugavelu, Karthik, et al.
Published: (2025-06-01)

SARS-CoV-2 Infection in Cancer Patients: Essential Aspects
by: Juan Santiago Serna Trejos, et al.
Published: (2023-01-01)

Possible Cases of SARS-CoV-2 Reinfection In Pekanbaru, Indonesia
by: Rahmat Azhari Kemal, et al.
Published: (2022-04-01)

Features of the formation of hybrid humoral immunity to SARS-CoV-2
by: L. P. Sizyakina, et al.
Published: (2025-07-01)

SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)